Notes from the Field: New Delhi metallo-β-lactamase-producing Escherichia coli associated with endoscopic retrograde cholangiopancreatography - Illinois, 2013
- PMID: 24381080
- PMCID: PMC4663693
Notes from the Field: New Delhi metallo-β-lactamase-producing Escherichia coli associated with endoscopic retrograde cholangiopancreatography - Illinois, 2013
Abstract
Infections with carbapenem-resistant Enterobacteriaceae (CRE) are increasing among patients in medical facilities. CRE that produce Klebsiella pneumoniae carbapenemase (KPC) have been responsible for much of the increase in the United States. However, New Delhi metallo-β-lactamase (NDM)-producing CRE have the potential to add to this burden. Since first reported in 2009, through 2012, 27 patients with NDM-producing CRE have been confirmed by CDC from isolates submitted by state laboratories. Since January 2013, a total of 69 patients with NDM-producing CRE have been identified in the United States; 44 patients were from northeastern Illinois.
References
-
- Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis. 2011;53:60–7. - PubMed
-
- Muscarella LF. Investigation and prevention of infectious outbreaks during endoscopic retrograde cholangiopancreatography. Endoscopy. 2010;42:957–9. - PubMed
-
- Alrabaa SF, Nguyen P, Sanderson R, et al. Early identification and control of carbapenemase-producing Klebsiella pneumoniae, originating from contaminated endoscopic equipment. Am J Infect Control. 2013;41:562–4. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
